How many studies have been conducted on Nogalamycin?

BiohacksAI has indexed 217 PubMed studies on Nogalamycin. 4% of studies involve human subjects.

What are the main research areas for Nogalamycin?

The primary research domains for Nogalamycin are 🔬 Oncology, ⚡ Energy & Fatigue, 🧠 Focus & Attention. This is based on analysis of 217 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Nogalamycin

An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.

217+ PubMed studies analyzed · Evidence Score: 40.2

Research Domains

Nogalamycin has been studied across 8 research domains including 🔬 Oncology, ⚡ Energy & Fatigue, 🧠 Focus & Attention, 🧠 Cognitive, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 18% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nogalamycin is generated deterministically from 217 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.